iShares Neuroscience and Healthcare ETF Rating $22.86 -0.53 (-2.27%) As of 06/13/2025 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatingsShort InterestBuy This Stock iShares Neuroscience and Healthcare ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBRN Aggregate RatingModerate Buy 2.86Holdings in IBRN have an aggregate rating of Moderate Buy based on 427 analyst ratings issued in the past year covering 47 companies (80.0% of the portfolio).IBRN Aggregate Price Target$22.86High Prediction$22.86Average Prediction$22.86Low Prediction$22.86Holdings in IBRN have an aggregate price target of $22.86 and a range of $22.86 to $22.86 covering 47 companies (80.0% of the portfolio).IBRN Consensus Ratings of HoldingsStrong Buy1 Strong Buy rating(s)Buy26 Buy rating(s)Moderate Buy14 Moderate Buy rating(s)Hold5 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Neuroscience and Healthcare ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 47 IBRN Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.42%ACADACADIA Pharmaceuticals$21.71-0.1%3.2269 of 5 stars2.69$26.79 23.4%16Analyst Revision5.10%CPRXCatalyst Pharmaceuticals$23.53-3.1%4.7678 of 5 stars3.25$32.83 39.5%8Gap Down4.80%NBIXNeurocrine Biosciences$124.39-0.5%4.9109 of 5 stars2.86$162.00 30.2%22Positive NewsAnalyst Revision4.29%PTCTPTC Therapeutics$51.26+0.5%3.8423 of 5 stars2.64$63.75 24.4%14Analyst RevisionGap Down4.27%ARGXargenx$577.89-1.5%3.4814 of 5 stars3.05$709.18 22.7%22Analyst Forecast4.12%SRRKScholar Rock$32.45-2.6%4.3808 of 5 stars3.14$42.67 31.5%7Gap Down4.00%ALKSAlkermes$29.83-3.1%4.6914 of 5 stars2.77$38.85 30.2%13Insider Trade3.89%SUPNSupernus Pharmaceuticals$32.03-2.3%2.1484 of 5 stars2.33$36.00 12.4%3Positive News3.82%BIIBBiogen$130.65-1.3%4.7326 of 5 stars2.38$188.19 44.0%32Trending NewsAnalyst Forecast3.81%DNLIDenali Therapeutics$14.55-2.5%4.335 of 5 stars3.06$33.71 131.7%17Positive NewsAnalyst RevisionGap Down3.75%XENEXenon Pharmaceuticals$32.76-0.1%3.6624 of 5 stars3.00$54.82 67.3%12Options VolumeAnalyst Revision2.72%DYNDyne Therapeutics$14.41-0.3%2.4414 of 5 stars3.00$44.93 211.8%15Positive NewsAnalyst ForecastGap Down2.47%BHVNBiohaven$15.43-1.1%2.9972 of 5 stars3.07$59.46 285.5%15Short Interest ↑Analyst Revision2.25%EWTXEdgewise Therapeutics$15.29-0.8%2.6529 of 5 stars2.78$39.78 160.2%9Gap Up1.97%IARTIntegra LifeSciences$12.16-4.2%4.471 of 5 stars1.78$18.63 53.2%9Gap Down1.89%AVDLAvadel Pharmaceuticals$9.57+2.5%2.3217 of 5 stars3.00$18.17 89.8%6Positive News1.84%PRAXPraxis Precision Medicines$44.30-1.6%2.7652 of 5 stars2.80$109.90 148.1%10Analyst Forecast1.81%SRPTSarepta Therapeutics$36.18-3.0%4.7069 of 5 stars2.87$122.61 238.9%231.50%AVXLAnavex Life Sciences$8.03-2.3%3.8503 of 5 stars3.33$44.00 447.9%3Positive NewsGap Down1.25%CAPRCapricor Therapeutics$11.78-15.5%2.2546 of 5 stars3.00$35.50 201.4%6Analyst ForecastOptions VolumeAnalyst RevisionGap Down1.07%ZVRAZevra Therapeutics$9.13-2.6%2.847 of 5 stars3.11$22.29 144.1%9Positive NewsAnalyst Revision1.01%AXGNAxoGen$9.75-2.9%2.637 of 5 stars3.00$22.20 127.7%5Positive News0.99%TSHATaysha Gene Therapies$2.54-4.2%3.8091 of 5 stars3.00$7.57 198.1%8Analyst ForecastAnalyst RevisionGap Up0.94%RGNXREGENXBIO$9.27-9.1%4.2847 of 5 stars2.83$31.63 241.2%6Gap Down0.84%NGNENeurogene$19.76-3.1%3.4758 of 5 stars2.71$45.40 129.8%7News CoverageAnalyst ForecastGap Down0.82%DNTHDianthus Therapeutics$18.31-5.1%1.371 of 5 stars3.13$53.00 189.5%8Analyst Revision0.79%CBLLCeriBell$17.27-5.0%2.6628 of 5 stars3.00$32.50 88.2%70.76%FULCFulcrum Therapeutics$6.85+1.0%0.4251 of 5 stars2.50$6.29 -8.2%8Positive NewsAnalyst RevisionGap Down0.76%AMLXAmylyx Pharmaceuticals$5.524.1366 of 5 stars3.11$9.83 78.1%9Analyst DowngradeGap Down0.73%CLPTClearPoint Neuro$11.54-4.5%2.5366 of 5 stars3.00$25.00 116.6%3News CoveragePositive NewsAnalyst UpgradeInsider Trade0.66%NPCENeuroPace$11.07-1.4%3.7246 of 5 stars2.83$15.50 40.0%6Analyst RevisionHigh Trading Volume0.60%SLDBSolid Biosciences$4.51-1.5%3.8688 of 5 stars3.23$14.90 230.4%13Positive NewsAnalyst RevisionGap Down0.58%ABEOAbeona Therapeutics$6.16-1.3%4.0672 of 5 stars3.00$19.25 212.5%5Positive NewsAnalyst Revision0.56%ANNXAnnexon$2.49-8.1%2.2196 of 5 stars3.00$12.50 402.0%3Positive NewsAnalyst Revision0.55%VNDAVanda Pharmaceuticals$4.51-2.6%4.6151 of 5 stars3.50$16.50 265.9%2News CoverageAnalyst UpgradeAnalyst Revision0.50%RAPPRapport Therapeutics$11.19+0.4%1.9513 of 5 stars3.00$32.67 191.9%4Positive News0.50%PRTAProthena$5.08+0.2%3.9152 of 5 stars2.33$31.50 520.1%9Positive NewsShort Interest ↓Analyst Revision0.41%TRDAEntrada Therapeutics$7.59-3.3%2.9028 of 5 stars3.25$25.67 238.2%4Positive NewsAnalyst DowngradeGap Down0.36%VYGRVoyager Therapeutics$3.30-8.3%4.4153 of 5 stars3.13$13.39 305.8%8News CoverageAnalyst RevisionGap Down0.26%DSGNDesign Therapeutics$3.84-1.8%0.7186 of 5 stars2.00$4.00 4.2%1Positive NewsGap Down0.23%ALECAlector$1.54-4.9%3.3263 of 5 stars2.14$4.00 159.7%7News CoverageShort Interest ↑Analyst RevisionGap Down0.22%SGMOSangamo Therapeutics$0.49-2.4%2.178 of 5 stars2.67$4.50 816.5%6Positive NewsGap Down0.20%LRMRLarimar Therapeutics$2.88-1.0%2.5221 of 5 stars3.11$19.67 582.9%9Short Interest ↓Gap Down0.19%SAVACassava Sciences$2.05-3.3%4.2679 of 5 stars2.50$54.50 2,558.5%2Positive News0.18%CLYMClimb Bio$1.26-1.6%3.0842 of 5 stars3.25$9.00 614.3%4Gap Down0.14%ANROAlto Neuroscience$2.42-1.4%1.6563 of 5 stars2.57$15.40 537.7%70.13%CTNMContineum Therapeutics$4.43-4.3%2.5478 of 5 stars3.20$22.50 407.9%5Positive NewsGap Up This page (NYSEARCA:IBRN) was last updated on 6/15/2025 by MarketBeat.com Staff From Our PartnersTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredBanks aren’t ready for this altcoin—are you?Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity i...Crypto 101 Media | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Neuroscience and Healthcare ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Neuroscience and Healthcare ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
